Model
Edge
CRISPR Therapeutics
0001968317
Filing Type
4
Filing Date
3/21/2024
Updated
3/22/24, 11:45 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership